Medrio
Company

Last deal

$30M

Amount

Venture - Series Unknown

Stage

24.05.2017

Date

4

all rounds

$32M

Total amount

General

About Company
Medrio is a San Francisco-based company that provides advanced electronic data capture and e-clinical tools for complex clinical trials.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2005

Number of employees

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

Medrio is a global leader in eClinical software and services used in decentralized, hybrid, and traditional clinical trials. Their web-based platform provides electronic data for clinical research applications and supports various processes for clinical research, study design, data collection, management reports, statistical analyses, and presentation. Medrio's suite of eClinical technologies and services includes EDC, eCOA, ePRO, eConsent, Randomization and Trial Supply Management (RTSM), and Direct Data Capture. They offer flexible, modular solutions tailored to the specific needs of their customers, with high-touch customer engagement, onboarding, and support services. Medrio has earned a 98% customer satisfaction rating and is trusted by contract research organizations (CROs), sponsors, and sites across all therapeutic areas and trial phases.
Contacts

Social url